TP53 and prostate carcinoma: Furthermore, the mechanism for LOH in TP53 is highly specific to tumour type, with ovarian cancers exhibiting LOH of the full chromosome 17 in 75% of samples, whereas in prostate cancer (also 70% LOH for TP53) this is nearly always caused by highly focal deletions.